IES-ACap: Influence of Atrial Pulse Width in the Behaviour of ACap™ Confirm Algorithm.
IES-ACap
Influence of Atrial Pulse Width in the Behaviour of ACap™ Confirm Algorithm.
1 other identifier
observational
70
0 countries
N/A
Brief Summary
The purpose of this observational study is to collect data regarding the population of patients with a pacemaker implanted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2009
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 29, 2009
CompletedFirst Posted
Study publicly available on registry
January 30, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedResults Posted
Study results publicly available
September 8, 2014
CompletedFebruary 20, 2019
February 1, 2019
2.4 years
January 29, 2009
August 27, 2014
February 1, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of Patients in Whom ACap™ Confirm Algorithm is Programmed Safely to ON During the First 12 Months.
12 months
Secondary Outcomes (1)
Percentage of Patients in Whom ACap™ Confirm Algorithm is Recommended at a Pulse Width of 0.4 Milliseconds (ms) During All Follow-ups (Implant, Staples Removal, 3, 6, 9 and 12 Months).
12 months
Eligibility Criteria
Patients whit a Zephyr™ pacemaker implanted, models 5826 and 5820.
You may qualify if:
- Patient has an indication for implantation of a dual-chamber pacemaker;
- Patient is older than 18 years of age
- Patient has signed the study specific Informed consent document.
- Primo implant.
You may not qualify if:
- Patient is pregnant or nursing
- Patient is less than 18 years of age
- Patient is in New York Heart Association (NYHA) class III and IV.
- Patient has a pacemaker replacement;
- Patient is unable to attend the follow-up visits;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. José Olagüe
- Organization
- Hospital Universitari i politecnic La Fe
Study Officials
- PRINCIPAL INVESTIGATOR
José Olagüe de Ros, PhD.
Hospital Universitario La Fe
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2009
First Posted
January 30, 2009
Study Start
January 1, 2009
Primary Completion
June 1, 2011
Study Completion
September 1, 2013
Last Updated
February 20, 2019
Results First Posted
September 8, 2014
Record last verified: 2019-02